Silke Gillessen

Institute of Oncology Research — Switzerland

Medicine · Health Sciences

79h-index32.3kcitations544works28.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Treatment and Research(301), Prostate Cancer Diagnosis and Treatment(113), Radiopharmaceutical Chemistry and Applications(100), Cancer, Lipids, and Metabolism(66), Testicular diseases and treatments(48)

Publications542 total

Drug re-purposing to improve outcomes in the management of prostate cancer – aims, outcome measures and design of current phase III trials
BMC Pharmacology and Toxicology·2026Open Access
Beyond Menopause: Ending the Inequality—Why Men with Prostate Cancer Still Lack Therapies for Hot Flushes
European Urology·2025
Capivasertib plus abiraterone in PTEN-deficient metastatic hormone-sensitive prostate cancer: CAPItello-281 phase III study
Annals of Oncology·2025
A plain language summary of the EORTC 1333/PEACE-3 study of enzalutamide alone vs enzalutamide plus radium-223 in patients with metastatic castrationresistant prostate cancer (mCRPC) and bone metastases
Future Oncology·2025Open Access
Predicting Toxicities and Survival Outcomes in De Novo Metastatic Hormone-Sensitive Prostate Cancer Using Clinical Features, Routine Blood Tests and Their Early Variations
Cancers·2025Open Access
Supplementary Table S1 from Randomized Phase II Cabazitaxel Dose Individualization and Neutropenia Prevention Trial in Patients with Metastatic Castration-Resistant Prostate Cancer
2025Open Access
Supplementary Figure S1 from Randomized Phase II Cabazitaxel Dose Individualization and Neutropenia Prevention Trial in Patients with Metastatic Castration-Resistant Prostate Cancer
2025Open Access
Supplementary Data from DNA Methylation Landscapes of Prostate Cancer Brain Metastasis Are Shaped by Early Driver Genetic Alterations
2025Open Access
Supplementary Data from DNA Methylation Landscapes of Prostate Cancer Brain Metastasis Are Shaped by Early Driver Genetic Alterations
2025Open Access
A roadmap for future clinical research in advanced prostate cancer: Findings from the Advanced Prostate Cancer Consensus Conference (APCCC) 2024
European Journal of Cancer·2025Open Access
ESUR: Opportunities for PSMA-PET/CT and whole-body MRI in advanced prostate cancer
European Radiology·2025· 3 citedOpen Access
Comparative Survival in Metastatic Hormone-sensitive Prostate Cancer by Volume of Disease and Timing of Metastasis: A Living Network Meta-analysis
European Urology·2025· 1 citedOpen Access
Case Report: Could genetic factors influence the outcomes of first-line enfortumab vedotin plus pembrolizumab therapy in patients with metastatic urothelial carcinoma? Two cases of patients harbouring a BRCA mutation
Frontiers in Oncology·2025Open Access
Venous thromboembolic event risk with PARP inhibitors in solid tumors: a systematic review and meta-analysis
ESMO Open·2025Open Access
<sup>177</sup> Lu-PSMA-617 Monotherapy Is Provocative but No Standard of Care for Metastatic Hormone-Sensitive Prostate Cancer
Journal of Nuclear Medicine·2025
SPARC: The Standardised Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Analysis and Reporting Consensus: A Delphi Analysis
European Urology·2025· 7 citedOpen Access
2420MO Effects of prostate radiotherapy (RT) on synchronous, metastatic, hormone-sensitive prostate cancer (mHSPC): STOPCAP meta-analysis of individual participant data (IPD)
Annals of Oncology·2025
Tumor transcriptome-wide expression classifiers predict treatment sensitivity in advanced prostate cancers
Cell·2025· 13 citedOpen Access
Activity of Platinum Monotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer and DNA Damage Repair Gene Alterations
JCO Precision Oncology·2025· 1 cited
oDigital pathology biomarkers for guiding radiotherapy-based treatment concepts in prostate cancer − a systematic review and expert consensus
Radiotherapy and Oncology·2025· 2 cited
page 1 of 28Next →

Frequent Co-authors

Axel Heidenreich(15), Karim Fizazi(13), Malcolm D. Mason(12), Nicholas D. James(11), Stefano Fanti(10), Gedske Daugaard(10), Maria De Santis(9), Ann Henry(9), Olivier Rouvière(9), Gerhardt Attard(9), Nicolas Mottet(8), Theodorus van der Kwast(8), Derya Tilki(8), Thomas Wiegel(8), Johann S. de Bono(8), Noel W. Clarke(8), Matthew R. Sydes(8), Jan Oldenburg(8), Carsten Bokemeyer(8), Robert Huddart(8)